Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) Gross Profit (2023 - 2025)

Historic Gross Profit for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to $698231.0.

  • BioScience Health Innovations' Gross Profit rose 6439.02% to $698231.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 14932.76%. This contributed to the annual value of $1.3 million for FY2024, which is 17020.42% up from last year.
  • According to the latest figures from Q3 2025, BioScience Health Innovations' Gross Profit is $698231.0, which was up 6439.02% from $1.1 million recorded in Q2 2025.
  • BioScience Health Innovations' Gross Profit's 5-year high stood at $1.1 million during Q2 2025, with a 5-year trough of $27591.0 in Q1 2023.
  • Moreover, its 3-year median value for Gross Profit was $310376.0 (2024), whereas its average is $405649.9.
  • The largest annual percentage gain for BioScience Health Innovations' Gross Profit in the last 5 years was 75086.8% (2024), contrasted with its biggest fall of 4333.75% (2024).
  • Over the past 3 years, BioScience Health Innovations' Gross Profit (Quarter) stood at $236511.0 in 2023, then soared by 43.34% to $339009.0 in 2024, then surged by 105.96% to $698231.0 in 2025.
  • Its last three reported values are $698231.0 in Q3 2025, $1.1 million for Q2 2025, and $896145.0 during Q1 2025.